Collegium Pharmaceutical's total assets for Q3 2025 were $1.61B, an increase of 0.92% from the previous quarter. COLL total liabilities were $1.33B for the fiscal quarter, a -2.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.